Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2116 AL 2130

Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies

Pazzin DB, Previato TTR, Budelon Gonçalves JI, Zanirati G, Xavier FAC, da Costa JC, Marinowic DR.

Cells. 2024 Apr 25;13(9):745. doi: 10.3390/cells13090745.

Exploration beyond osteoarthritis: the association and mechanism of its related comorbidities

Li B, Yang Z, Li Y, Zhang J, Li C, Lv N.

Front Endocrinol (Lausanne). 2024 Apr 19;15:1352671. doi: 10.3389/fendo.2024.1352671. eCollection 2024.

Indanone: a promising scaffold for new drug discovery against neurodegenerative disorders

Bansal R, Singh R, Dutta TS, Dar ZA, Bajpai A.

Drug Discov Today. 2024 Aug;29(8):104063. doi: 10.1016/j.drudis.2024.104063. Epub 2024 Jun 18.

Frailty for neurologists: perspectives on how frailty influences care planning

Canevelli M, Jackson-Tarlton C, Rockwood K.

Lancet Neurol. 2024 Nov;23(11):1147-1157. doi: 10.1016/S1474-4422(24)00291-6. Epub 2024 Sep 11.

CNS disease associated with enhanced type I interferon signalling

Crow YJ.

Lancet Neurol. 2024 Nov;23(11):1158-1168. doi: 10.1016/S1474-4422(24)00263-1.

Advances in Blood Biomarkers and Diagnosis Approaches for Neurodegenerative Dementias and Related Diseases

Sekimori T, Fukunaga K, Finkelstein DI, Kawahata I.

J Integr Neurosci. 2024 Oct 10;23(10):188. doi: 10.31083/j.jin2310188.

Prevention of Aspiration: Oral Care, Antibiotics, Others

Perticone ME, Manti A, Luna CM.

Semin Respir Crit Care Med. 2024 Dec;45(6):709-716. doi: 10.1055/s-0044-1793812. Epub 2024 Nov 29.

Mitochondrial Dynamics in Brain Cells During Normal and Pathological Aging

Sukhorukov VS, Baranich TI, Egorova AV, Akateva AV, Okulova KM, Ryabova MS, Skvortsova KA, Dmitriev OV, Mudzhiri NM, Voronkov DN, Illarioshkin SN.

Int J Mol Sci. 2024 Nov 29;25(23):12855. doi: 10.3390/ijms252312855.

Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imaging

Dadu A, Ta M, Tustison NJ, Daneshmand A, Marek K, Singleton AB, Campbell RH, Nalls MA, Iwaki H, Avants B, Faghri F.

medRxiv [Preprint]. 2024 Oct 28:2024.10.27.24316215. doi: 10.1101/2024.10.27.24316215.

Equine Pergolide Toxicity: A Case Series

Ebeling-Koning NE, Fowler JT Jr, DelBianco JD, Surmaitis RM.

Cureus. 2024 Jul 10;16(7):e64265. doi: 10.7759/cureus.64265. eCollection 2024 Jul.

Delayed clinical response to focused ultrasound thalamotomy in essential tremor in a patient with suboptimal skull density ratio - A case report

Chowdhury EA, Sivan V, Kumar RP, Ruzicka Iv FF, Azmi H.

Surg Neurol Int. 2024 Nov 8;15:406. doi: 10.25259/SNI_707_2024. eCollection 2024.

Coexisting Logopenic Variant of Primary Progressive Aphasia with Amyloid Pathology and Early Parkinsonism

Caccamo M, Urso D, Nanni AG, Gnoni V, Giugno A, Vitulli A, Vilella D, Zecca C, Dell'Abate MT, Anastasia A, De Blasi R, Introna A, Logroscino G.

J Alzheimers Dis Rep. 2024 Jun 25;8(1):1023-1030. doi: 10.3233/ADR-230168. eCollection 2024.

Update: Protective and risk factors for Parkinson disease

Grotewold N, Albin RL.

Parkinsonism Relat Disord. 2024 Aug;125:107026. doi: 10.1016/j.parkreldis.2024.107026. Epub 2024 Jun 13.

Review of the therapeutic potential of Forsythiae Fructus on the central nervous system: Active ingredients and mechanisms of action

Zhang L, Lang F, Feng J, Wang J.

J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117275. doi: 10.1016/j.jep.2023.117275. Epub 2023 Oct 4.

Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases

Chudzik A, Śledzianowski A, Przybyszewski AW.

Sensors (Basel). 2024 Feb 29;24(5):1572. doi: 10.3390/s24051572.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias